CIAS
BSX icon

Capital Investment Advisory Services’s Boston Scientific BSX Stock Holding History

Capital Investment Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,807
Closed -$74K – 642
2019
Q3 		$74K Sell
1,807
-71
-4% -$3.01K 0.02% 460
2019
Q2 		$80K Buy
1,878
+71
+4% +$2.73K 0.02% 437
2019
Q1 		$69K Hold
1,807
– – 0.03% 417
2018
Q4 		$64K Buy
+1,807
New +$65.5K 0.03% 406

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Capital Investment Advisory Services's BSX Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 1,807 shares — an estimated $74K sold.

Capital Investment Advisory Services first reported a position in BSX in Q4 2018 and held it in 4 quarters. The position peaked at $80K in Q2 2019. 853 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 1,807 Boston Scientific shares in Q4 2019, an estimated $74K.
  • Capital Investment Advisory Services first reported a position in Boston Scientific in Q4 2018 and held it in 4 quarters.
  • Capital Investment Advisory Services's Boston Scientific position peaked at $80K in Q2 2019.
  • 853 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.